CAD 50,000.00
Reported federal agreement value. An agreement can cover several years; this is not the amount paid out.
Selected because the publisher reports recipient province NL; NL Ledger has not established the work, benefit or jurisdiction from this record; source fields are available below.
This is the whole reported commitment or notice value, not the amount paid or an NL allocation.
- Recipient
- JRAS Medical Inc.
- Public body
- National Research Council Canada
- Agreement start
- Sept. 1, 2020
- Program
- Industrial Research Assistance Program – Contributions to Firms
- Record type
- Federal grant or contribution
Receipt
agreement 172-2020-2021-Q2-956438, amendment 0
Source location evidence
Location review incomplete.
Reported address: country: CA; province: NL; city: St. John's|St. John's; postal code: A1C 2Z4.
How counted: latest of 1 rows (department reports running totals). Start: 2020-09-01; end: 2021-03-31; reported: not stated. Amount: published value.
Full source fields
- _id
- 35895851
- ref_number
- 172-2020-2021-Q2-956438
- amendment_number
- 0
- amendment_date
- agreement_type
- C
- recipient_type
- F
- recipient_business_number
- 767414923
- recipient_legal_name
- JRAS Medical Inc.
- recipient_operating_name
- research_organization_name
- recipient_country
- CA
- recipient_province
- NL
- recipient_city
- St. John's|St. John's
- recipient_postal_code
- A1C 2Z4
- federal_riding_name_en
- St. John's East
- federal_riding_name_fr
- St. John's-Est
- federal_riding_number
- 10006
- prog_name_en
- Industrial Research Assistance Program – Contributions to Firms
- prog_name_fr
- Programme d’aide à la recherche industrielle – Contributions aux entreprises
- prog_purpose_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- prog_purpose_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- agreement_title_en
- Remote Monitoring of the Jugular Venous Pressure: A home monitoring solution for congestive heart failure
- agreement_title_fr
- Surveillance à distance de la pression veineuse jugulaire : une solution de surveillance à domicile pour l'insuffisance cardiaque congestive
- agreement_number
- 956438
- agreement_value
- 50000
- foreign_currency_type
- foreign_currency_value
- agreement_start_date
- 2020-09-01
- agreement_end_date
- 2021-03-31
- coverage
- IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
- description_en
- The JVPHome is a medical device enabling remote monitoring of heart failure patients following discharge from hospital. Heart failure is a life-threatening disorder with ~ 25% of patients being readmitted to hospital within 30 days following initial discharge. The JVPHome promises to dramatically reduce these readmissions by enabling clinicians to remotely visualize the jugular venous pressure (JVP; neck vein height) and adjust medications to prevent recurrent heart failure. Although the JVP can be visually identified, its identification remains a challenge. The Covid-19 pandemic has highlighted more than ever the importance of effective home monitoring solutions for patients with chronic diseases such as congestive heart failure.
- description_fr
- Le JVPHome est un dispositif médical qui permet de surveiller à distance les patients souffrant d'insuffisance cardiaque après leur sortie de l'hôpital. L'insuffisance cardiaque est un trouble qui met la vie en danger. Environ 25 % des patients sont réadmis à l'hôpital dans les 30 jours suivant leur sortie initiale. Le JVPHome promet de réduire considérablement ces réadmissions en permettant aux cliniciens de visualiser à distance la pression veineuse jugulaire (PVJ; hauteur de la veine du cou) et d'ajuster les médicaments pour prévenir les insuffisances cardiaques récurrentes. Bien que la PVJ puisse être repérée visuellement, son repérage reste un défi. La pandémie de la Covid-19 a plus que jamais souligné l'importance de solutions efficaces de surveillance à domicile pour les patients atteints de maladies chroniques telles que l'insuffisance cardiaque congestive.
- naics_identifier
- 339110
- expected_results_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- expected_results_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- additional_information_en
- additional_information_fr
- owner_org
- nrc-cnrc
- owner_org_title
- National Research Council Canada | Conseil national de recherches Canada
Spot an error? Say so in the box below, or email corrections@nlledger.ca. What to send.